Company Valuation: CS Diagnostics Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 0.3951 150.6 76.47
Change - 38,005.96% -49.21%
Enterprise Value (EV) 1 0.3747 150.6 76.47
Change - 40,076.48% -49.21%
P/E -2,525x 232,000x 1,077x
PBR 0.11x 0.32x 0.15x
PEG - -2,263x 0x
Capitalization / Revenue 3.13x 1,357x 375x
EV / Revenue 2.97x 1,357x 375x
EV / EBITDA - - -
EV / EBIT -17x 197,840x 1,074x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.000198 0.000005 0.000284
Distribution rate - - -
Net sales 1 0.126 0.1109 0.204
EBITDA - - -
EBIT 1 -0.022 0.000761 0.0712
Net income 1 -0.022 0.000761 0.0712
Net Debt 1 -0.0204 -0.000501 -0.006813
Reference price 2 0.500000 1.160000 0.305900
Nbr of stocks (in thousands) 790 129,790 249,992
Announcement Date 29/07/25 29/07/25 15/04/26
1USD in Million2USD
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 1.82M
34.6x4.09x15.38x2.48% 181B
24.27x4.74x16.63x1.15% 120B
20.89x3.59x12.86x2.92% 119B
31.27x3.02x12.17x2.28% 91.44B
18.13x0.21x13.12x0.72% 63.07B
31.81x7.93x20.4x1.24% 55.8B
39.34x3.62x12.34x2.11% 54.03B
39.01x9.68x27.09x-.--% 45.38B
44.15x3.33x12.39x0.52% 34.37B
Average 31.49x 4.47x 15.82x 1.49% 76.35B
Weighted average by Cap. 29.91x 4.21x 15.32x 1.82%

Y-o-Y evolution of P/E

Valuation ratios - P/E - CS Diagnostics Corp.

Historical PBR trend

Valuation ratios - PBR - CS Diagnostics Corp.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - CS Diagnostics Corp.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - CS Diagnostics Corp.

  1. Stock Market
  2. Stocks
  3. CSDX Stock
  4. Valuation CS Diagnostics Corp.